Proposed Data Collections Submitted for Public Comment and Recommendations, 8190-8191 [2014-02937]

Download as PDF 8190 Federal Register / Vol. 79, No. 28 / Tuesday, February 11, 2014 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–14–0923] Proposed Data Collections Submitted for Public Comment and Recommendations The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. chapter 35). To request a copy of these requests, call (404) 639–7570 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project Evaluation of the CDC National Tobacco Prevention and Control Public Education Campaign (OMB No. 0920– 0923, exp. 4/30/2014)—Revision— National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description The Centers for Disease Control and Prevention (CDC) requests OMB approval to conduct a multi-wave longitudinal study of smokers and nonsmokers in the U.S. Information collection will consist of an initial wave 1 survey and a series of follow-up surveys (4 follow-ups among smokers, 3 follow-ups among nonsmokers) to assess long-term, lasting impacts of CDC’s National Tobacco Education Campaign. Phase 3 of the campaign is expected to launch in February 2014. The timeframe for information collection correlates with the timing and duration of the campaign. In order to ensure accurate measurement of campaign awareness after all media have been aired, CDC anticipates fielding the first survey from March to June 2014. Participants who complete the wave 1 survey will be surveyed again in a follow-up survey approximately 3 months later. This will facilitate analysis of relationships between individuals’ exposure to the campaign and changes in outcomes of interest. Subsequent follow-up surveys (3 for smokers, 2 for nonsmokers) will occur on a quarterly basis after the first two surveys are completed. One of the primary purposes of the subsequent follow-up surveys will be to track longer-term cigarette abstinence among smokers who initially report quitting as a result of the campaign. This study will rely on Web surveys to be self-administered on computers in the respondent’s home or in another convenient location. Information will be collected about smokers’ and nonsmokers’ awareness of and exposure to specific campaign advertisements, knowledge, attitudes, beliefs related to smoking and secondhand smoke, and other marketing exposure. The surveys will also measure behaviors related to smoking cessation (among the smokers in the sample) and behaviors related to non-smokers’ encouragement of smokers to quit smoking, recommendations of cessation services, and attitudes about other tobacco and nicotine products. Follow-up surveys may include additional survey items on other relevant topics, including cigars, noncombustible tobacco products, and other emerging trends in tobacco use. It is important to evaluate CDC’s campaign in a context that assesses the dynamic nature of tobacco product marketing and uptake of various tobacco products, particularly since these may affect successful cessation rates. The sample for this survey will originate from two sources: (1) A new online longitudinal cohort of smokers and nonsmokers, sampled randomly from postal mailing addresses in the U.S. (address-based sample, or ABS); and (2) the existing GfK KnowledgePanel, an established longterm online panel of U.S. adults. The new ABS-sourced longitudinal cohort will consist of smokers and nonsmokers who have not previously participated in any established online panels. The new cohort will be recruited by GfK, utilizing identical recruitment methods that are used in the recruitment of KnowledgePanel. The GfK KnowledgePanel will be used in combination with the new ABS-sourced cohort to support larger sample sizes that will allow for more in-depth subgroup analysis, which is a key objective of the CDC. All online surveys, regardless of sample source, will be conducted via the GfK KnowledgePanel Web portal for self-administered surveys. Respondents may participate in English or Spanish. OMB approval is requested for two years. Participation is voluntary and there are no costs to respondents other than their time. The total estimated annualized burden hours are 8,777. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Form name General Population ......................................... Adults, ages 18–54 in the U.S. ....................... tkelley on DSK3SPTVN1PROD with NOTICES Type of respondent Screening and Consent Process ................... Smoker Wave 1 Survey ................................. Smoker Follow-Up Survey (Wave 2) ............. Smoker Follow-Up Survey (Wave 3) ............. Smoker Follow-Up Survey (Wave 4) ............. Smoker Follow-Up Survey (Wave 5) ............. Nonsmoker Wave 1 Survey ........................... Nonsmoker Follow-Up Survey (Wave 2) ....... Nonsmoker Follow-Up Survey (Wave 3) ....... Nonsmoker Follow-Up Survey (Wave 4) ....... VerDate Mar<15>2010 17:58 Feb 10, 2014 Jkt 232001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\11FEN1.SGM 13,074 4,720 1,982 1,982 1,982 1,982 1,400 441 442 442 11FEN1 Number of responses per respondent Average burden per response (in hours) 1 1 1 1 1 1 1 1 1 1 5/60 30/60 30/60 30/60 30/60 30/60 30/60 30/60 30/60 30/60 Federal Register / Vol. 79, No. 28 / Tuesday, February 11, 2014 / Notices Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2014–02937 Filed 2–10–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC): Notice of Charter Renewal This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Advisory Committee to the Director, Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS), has been renewed for a 2-year period extending through February 1, 2016. Contact Person for More Information: Carmen Villar, M.S.W., Designated Federal Officer, Advisory Committee to the Director, CDC, 1600 Clifton Road, NE., Mailstop D14, Atlanta, Georgia 30333, Telephone 404–639–7000. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–02881 Filed 2–10–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES tkelley on DSK3SPTVN1PROD with NOTICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns NIOSH Member Conflict Review, PA 07–318, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease VerDate Mar<15>2010 17:58 Feb 10, 2014 Jkt 232001 Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 1:00 p.m.–4:00 p.m., March 13, 2014 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘NIOSH Member Conflict Review, PA 07–318. Contact Person for More Information: Nina Turner, Ph.D., Scientific Review Officer, 1095 Willowdale Road, Morgantown, WV 26506, Telephone: (304) 285–5976. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–02856 Filed 2–10–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Reduction of Malaria in U.S. Residents Returning from Overseas Travel to Malaria-Endemic Countries, FOA CK14–004, Initial Review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 12:00 p.m.–4:00 p.m., March 18, 2014 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Reduction of Malaria in U.S. Residents Returning from Overseas Travel to Malaria-Endemic Countries, FOA CK14– 004’’. PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 8191 Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718–8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–02857 Filed 2–10–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Council for the Elimination of Tuberculosis (ACET) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Time and Date: 11:00 a.m.–4:10 p.m., March 4, 2014. Place: This meeting is accessible by Web conference. Toll-free +1 (800) 857–9642, Participant Code: 4131105 For Participants: URL: https://www.mymeetings.com/nc/join/ Conference number: PW3964772 Audience passcode: 4131105 Participants can join the event directly at: https://www.mymeetings.com/nc/join.php?i= PW3964772&p=4131105&t=c Status: Open to the public limited only by web conference. Participation by web conference is limited by the number of 100 ports available. Purpose: This council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. Matters To Be Discussed: Agenda items include the following topics: (1) U.S. Prevention Services Task Force and Medicaid coverage for tuberculosis (TB); (2) Update on CDC Global TB issues; (3) Updates from Workgroups; and (4) other tuberculosisrelated issues. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Margie Scott-Cseh, Centers for Disease E:\FR\FM\11FEN1.SGM 11FEN1

Agencies

[Federal Register Volume 79, Number 28 (Tuesday, February 11, 2014)]
[Notices]
[Pages 8190-8191]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-02937]

[[Page 8190]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-14-0923]

Proposed Data Collections Submitted for Public Comment and
Recommendations

The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. chapter 35). To request a copy of these requests, call
(404) 639-7570 or send an email to omb@cdc.gov. Send written comments
to CDC Desk Officer, Office of Management and Budget, Washington, DC
20503 or by fax to (202) 395-5806. Written comments should be received
within 30 days of this notice.

Proposed Project

Evaluation of the CDC National Tobacco Prevention and Control
Public Education Campaign (OMB No. 0920-0923, exp. 4/30/2014)--
Revision--National Center for Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

The Centers for Disease Control and Prevention (CDC) requests OMB
approval to conduct a multi-wave longitudinal study of smokers and non-
smokers in the U.S. Information collection will consist of an initial
wave 1 survey and a series of follow-up surveys (4 follow-ups among
smokers, 3 follow-ups among nonsmokers) to assess long-term, lasting
impacts of CDC's National Tobacco Education Campaign. Phase 3 of the
campaign is expected to launch in February 2014.
The timeframe for information collection correlates with the timing
and duration of the campaign. In order to ensure accurate measurement
of campaign awareness after all media have been aired, CDC anticipates
fielding the first survey from March to June 2014. Participants who
complete the wave 1 survey will be surveyed again in a follow-up survey
approximately 3 months later. This will facilitate analysis of
relationships between individuals' exposure to the campaign and changes
in outcomes of interest. Subsequent follow-up surveys (3 for smokers, 2
for nonsmokers) will occur on a quarterly basis after the first two
surveys are completed. One of the primary purposes of the subsequent
follow-up surveys will be to track longer-term cigarette abstinence
among smokers who initially report quitting as a result of the
campaign.
This study will rely on Web surveys to be self-administered on
computers in the respondent's home or in another convenient location.
Information will be collected about smokers' and non-smokers' awareness
of and exposure to specific campaign advertisements, knowledge,
attitudes, beliefs related to smoking and secondhand smoke, and other
marketing exposure. The surveys will also measure behaviors related to
smoking cessation (among the smokers in the sample) and behaviors
related to non-smokers' encouragement of smokers to quit smoking,
recommendations of cessation services, and attitudes about other
tobacco and nicotine products.
Follow-up surveys may include additional survey items on other
relevant topics, including cigars, noncombustible tobacco products, and
other emerging trends in tobacco use. It is important to evaluate CDC's
campaign in a context that assesses the dynamic nature of tobacco
product marketing and uptake of various tobacco products, particularly
since these may affect successful cessation rates.
The sample for this survey will originate from two sources: (1) A
new online longitudinal cohort of smokers and nonsmokers, sampled
randomly from postal mailing addresses in the U.S. (address-based
sample, or ABS); and (2) the existing GfK KnowledgePanel, an
established long-term online panel of U.S. adults. The new ABS-sourced
longitudinal cohort will consist of smokers and nonsmokers who have not
previously participated in any established online panels. The new
cohort will be recruited by GfK, utilizing identical recruitment
methods that are used in the recruitment of KnowledgePanel. The GfK
KnowledgePanel will be used in combination with the new ABS-sourced
cohort to support larger sample sizes that will allow for more in-depth
subgroup analysis, which is a key objective of the CDC. All online
surveys, regardless of sample source, will be conducted via the GfK
KnowledgePanel Web portal for self-administered surveys. Respondents
may participate in English or Spanish.
OMB approval is requested for two years. Participation is voluntary
and there are no costs to respondents other than their time. The total
estimated annualized burden hours are 8,777.

Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
General Population................. Screening and Consent 13,074 1 5/60
Process.
Adults, ages 18-54 in the U.S...... Smoker Wave 1 Survey....... 4,720 1 30/60
Smoker Follow-Up Survey 1,982 1 30/60
(Wave 2).
Smoker Follow-Up Survey 1,982 1 30/60
(Wave 3).
Smoker Follow-Up Survey 1,982 1 30/60
(Wave 4).
Smoker Follow-Up Survey 1,982 1 30/60
(Wave 5).
Nonsmoker Wave 1 Survey.... 1,400 1 30/60
Nonsmoker Follow-Up Survey 441 1 30/60
(Wave 2).
Nonsmoker Follow-Up Survey 442 1 30/60
(Wave 3).
Nonsmoker Follow-Up Survey 442 1 30/60
(Wave 4).
----------------------------------------------------------------------------------------------------------------

[[Page 8191]]

Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.

[FR Doc. 2014-02937 Filed 2-10-14; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.